"Sixth, as you've all heard in the past considerable effort is being devoted to the Xcede Patch technology. We are in negotiations with strategic partners for support on the clinical trial, manufacturing and raw materials requirements and with investment banks on the funding and strategic requirements. We're also at a point in the Company lifecycle, where we need to build a management team and are negotiations on that part as well. I know, a number of our shareholders are following developments here closely and we anticipate announcements very soon on the product development and management side. One very positive note, the underlying patent on this technology has been issues and we're continuing the legal work around the IP for this revolutionary technology."
"Fourth, R&D has a backlog of approximately $36 million reflecting awarded projects across varied scientific disciplines. But fortunately, continuing government budget pressures coupled with the Department of Homeland Security, operating under a continuing resolution, has resulted in variability and a lack of predictability in the funding of approved projects. We are managing R&D as considerately as possible reflective of this reality. We are hopeful that this situation will improve over the next several quarters, as the funding on approved projects is appropriated. If realized, this should stand a decline in R&D revenues."
"In addition we have invested approximately $400,000 in cutting and processing equipments as over in anticipation of substantial demand for one of our synthetic crystal lines. And we’ll likely double this investment in next six months. We expect to complete our equipment purchases, installation and lead some improvements in the current quarter, along with negotiations with this customer. The potential revenue for this product is significant."
"We expect to end the year with excess of $1 million in quick revenue and a backlog in excess of $500,000. Prior year revenue was negligible for this product. Quick crystals are now being used in both handheld and pager sized radiation detectors produced by thermal friction. We expect the Quick revenue to continue to grow over next several years as additional OEM customers consider it and engineer it into future products."
I very much doubt it will be another 2 quarters before big jump in price. Dysl has 3 or more possibilities for Xcede, it's just finding out what is best for the company and shareholders. The Xcede news can come any day from now on. This news will cause a big jump in PPS. This deal will ramp up Q results as well. This in together with sales ramping up... A PPS of 1.3 is just ridiculous at this point. We should at least be around 3 dollar right now. I'm adding if i have some cash free. glta
The research backlog for the Contracts Research segment has increased approximately $8 million from December 31, 2014 to $36 million at March 31, 2015 of which approximately $10 million is currently funded and in the process of being fulfilled.
Waiting for the call now. Gn
well i find it very strange. Normally Dysl brings out Q results pre market. Looks like it will be after market today. I got my info from a very trustful source. Q results followed by a call today.
expecting some news about Xcede this month... imo there will be more than one opportunity to go with Xcede and is management is taking it's time to make the best choice for DYSL and it shareholders. glta
The xcede outcome will soon hit the market... Within this and 2 months the deal will be closed and we at least will double our money imo. Sulick is doing everything right the xcede deal will directly make us money and the DYSL figures will improve on that to. Gltu
This CEO is doing all things right. He said they where working hard on the Xcede deal. All things are looking good and as we all saw last week, Mr Sulick is putting his own money into the company. He also said to hold on to my investment and that I will be very happy with my investment soon. I'm adding more soon. glta